Melanotan 2 (MT-2) is a synthetic, cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH) evaluated in preclinical research for non-selective melanocortin receptor activity. PX1 Research supplies analytical-grade [Melanotan 2 10 mg vials](/product/mtii-melanotan2-10mg) backed by USA synthesis, lot-specific HPLC/MS and endotoxin COAs, and same-day dispatch from our California and Arizona logistics hubs.
Melanotan 2 (MT-2) is a synthetic, cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH) evaluated in preclinical research for non-selective melanocortin receptor activity. PX1 Research supplies analytical-grade [Melanotan 2 10 mg vials](/product/mtii-melanotan2-10mg) backed by USA synthesis, lot-specific HPLC/MS and endotoxin COAs, and same-day dispatch from our California and Arizona logistics hubs.
Melanotan 2 is a synthetic cyclic peptide designed as a structural analog of endogenous alpha-melanocyte-stimulating hormone (α-MSH). In preclinical models, researchers evaluate MT-2 to understand non-selective agonism across the melanocortin receptor family, particularly MC1R, MC3R, MC4R, and MC5R.
Primary in vitro and animal research focuses on melanogenesis, examining how receptor stimulation activates adenylate cyclase and elevates intracellular cyclic adenosine monophosphate (cAMP) levels in melanocytes.
When evaluating what is Melanotan 2 for laboratory application, chemical integrity is paramount. Reference-standard research requires high-purity lyophilized powder verified by High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to ensure accurate molecular weight and absence of synthesis truncations.
PX1 Research provides fully documented research peptides manufactured under strict quality standards. Every lot undergoes independent third-party analysis for purity, identity, and bacterial endotoxin compliance prior to domestic release.
To understand what is Melanotan 2, investigators must look at its origin as a modified peptide derived from native α-MSH. Naturally occurring α-MSH is a linear peptide tridecapeptide responsible for regulating skin pigmentation response via melanocortin receptors. However, native α-MSH possesses a brief plasma half-life and rapid enzymatic degradation, limiting its utility in extended bench research.
Developed at the University of Arizona, Melanotan 2 (CAS 121062-08-6) was engineered as a lactam-bridged cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2. Incorporating D-phenylalanine at position 7 and forming a cyclic lactam ring between Aspartic Acid and Lysine residues confers significant metabolic stability and resistance to central serine proteases.
Because of this modified lactam structure, MT-2 exhibits enhanced receptor binding affinity compared to endogenous ligands. In benchtop biochemical investigations, researchers utilize MT-2 10 mg vials to model sustained melanocortin activation without the rapid degradation profiles observed with un-modified linear peptide sequences.
Melanotan 2 acts as a potent non-selective agonist across multiple G-protein coupled melanocortin receptors (MCRs). Preclinical binding assays establish distinct receptor affinities across the subtype panel, providing a versatile tool for cell signaling research:
• MC1R (Melanocortin 1 Receptor): Predominantly expressed on dermal melanocytes. Agonism at MC1R stimulates adenylate cyclase, increasing intracellular cyclic AMP (cAMP). This cascade upregulates microphthalmia-associated transcription factor (MITF), driving transcription of tyrosinase and promoting melanogenesis (eumelanin synthesis).
• MC3R & MC4R (Melanocortin 3 and 4 Receptors): Expressed extensively in central nervous system structures, including the hypothalamus. In preclinical rodent models, central MC3R/MC4R activation is studied for its downstream effects on energy homeostasis, metabolic regulation, and central signaling pathways.
• MC5R (Melanocortin 5 Receptor): Expressed in exocrine tissues, including sebaceous glands. In vitro models utilize MT-2 to investigate exocrine secretion mechanisms and peripheral receptor crosstalk.
Because MT-2 lacks subtype selectivity, cell culture experiments and binding assays must account for cross-activation across all four MCR subtypes. Researchers comparing receptor-specific responses often cross-reference data against linear analogs or selective sub-type agonists documented in our peptide research library.
In published scientific literature, Melanotan 2 is primarily researched for melanocortin activity related to skin pigmentation responses. Laboratory models focus on understanding how exogenous peptide agonists influence the cascade of enzymatic steps that convert L-tyrosine into eumelanin within specialized lysosome-like organelles called melanosomes.
In vitro cultures of human and murine melanocytes expose cell populations to varying nanomolar concentrations of MT-2. Researchers measure tyrosinase enzyme expression, cellular cAMP accumulation, and overall melanin density over 24- to 72-hour observation windows. These studies demonstrate that MT-2 induces dose-dependent increases in pigment production without requiring ultraviolet radiation exposure to initiate the primary signaling cascade.
In vivo preclinical models involve controlled administration in rodent species to quantify physiological shifts in skin tone, hair follicle pigmentation changes, and systemic receptor distribution. Investigators analyze skin tissue biopsies via immunohistochemistry to map receptor density and track intracellular melanosome translocation.
When designing a research protocol, labs often evaluate Melanotan 2 alongside other synthetic melanocortin analogs to contrast selectivity, receptor binding dynamics, and structural stability. The primary related compounds include:
• Melanotan 1 (Afamelanotide): A linear 13-amino-acid peptide analog of α-MSH (Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2). Unlike MT-2, Melanotan 1 retains a linear backbone and exhibits higher specificity for MC1R relative to central receptor subtypes. Read more in our detailed Melanotan 2 research overview.
• PT-141 (Bremelanotide): A active metabolite structure closely derived from MT-2. PT-141 is a cyclic peptide that lacks the C-terminal amide modification of MT-2 in specific structural variants and is researched heavily in central MC3R/MC4R signaling models. Comparative studies frequently pair MT-2 with PT-141 research vials to isolate central versus peripheral receptor outcomes.
Choosing between these compounds depends on whether your assay requires non-selective pan-agonism (MT-2), peripheral MC1R-targeted melanogenesis (MT-1), or central melanocortin receptor mapping (PT-141).
Reproducibility in peptide research depends directly on chemical purity and sequence accuracy. Low-purity compounds introduce uncontrolled chemical variables, including residual cleavage reagents, deletion sequences, and bacterial toxins, which can distort cell viability assays and receptor binding kinetics.
A rigorous quality assurance protocol for Melanotan 2 must verify four critical technical specifications:
1. HPLC Purity ≥ 99.0%: High-Performance Liquid Chromatography must confirm a single primary peak at the expected retention time, limiting synthesis impurities and truncated sequences to less than 1.0% total area.
2. Mass Spectrometry Identity: Electrospray Ionization Mass Spectrometry (ESI-MS) must verify the exact molecular mass (1024.2 g/mol for free base MT-2) to ensure correct cyclization and amino acid sequence order.
3. Residual TFA Control: Synthetic peptides purified via trifluoroacetic acid (TFA) salt exchange must be monitored. Excess free TFA in lyophilized cakes can cause localized pH drops in physiological buffer solutions, leading to cell toxicity in delicate in vitro cultures.
4. Bacterial Endotoxin Testing: Quantitative Chromogenic LAL (Limulus Amebocyte Lysate) testing must demonstrate endotoxin levels below 0.05 EU/mg to prevent non-specific inflammatory signaling in cell lines.
Selecting a reliable peptide supplier requires objective comparison across verifiable operational and quality criteria. The table below outlines standard vendor benchmarks required for rigorous scientific experimentation:
• Purity Verification: Third-party HPLC analysis performed per production lot (Standard: >98%; PX1 Research: ≥99% guaranteed).
• Identity Confirmation: Mass spectrometry (MS) trace provided for every batch to verify exact molecular weight and cyclization.
• Sourcing & Synthesis: USA-based synthesis and domestic laboratory processing to eliminate international transit degradation.
• Lot Traceability: Individual lot numbers printed directly on vial labels, linking directly to downloadable digital COAs.
• Endotoxin Control: Fluorogenic or chromogenic LAL testing verified on every finished batch prior to sales distribution.
• Dispatch Speed: Same-day shipping cutoffs (M–F) with temperature-controlled handling to preserve peptide structure.
• Support Infrastructure: Responsive technical assistance staffed by researchers familiar with analytical peptide handling.
The online vendor landscape for research peptides contains significant variability in quality control. Academic institutions and corporate laboratories should avoid suppliers that exhibit any of the following technical red flags:
• Generic or Recycled COAs: Certificates of Analysis that lack specific lot numbers, run dates, or third-party laboratory credentials. A valid COA must reflect the exact lot shipped to your facility.
• Non-Lyophilized Pre-Mixed Liquids: Authentic research peptides are unstable in aqueous liquid solutions at room temperature for extended periods. MT-2 must be supplied as a sterile, lyophilized (freeze-dried) cake in a sealed glass vial.
• Vendor Claims of Medical Efficacy: Any supplier marketing peptides with dosage guidelines, human administration instructions, or therapeutic claims operates outside proper regulatory and scientific compliance standards.
• Absence of Mass Spectrometry Data: Vendors relying solely on basic HPLC without mass spec validation cannot confirm cyclic ring closure or missing amino acid deletion impurities.
PX1 Research protects lab integrity by pairing every batch of Melanotan 2 10 mg with lot-matched, verifiable analytical documentation.
To preserve structural integrity and prevent peptide aggregation, proper reconstituted handling protocols must be observed in the laboratory environment:
• Storage of Dry Powder: Unreconstituted lyophilized MT-2 vials should be stored at -20°C upon receipt for long-term stability. Lyophilized cakes remain stable at controlled room temperature (20–25°C) during short-term transit.
• Reconstitution Medium: Reconstitute using sterile Bacteriostatic Water (0.9% benzyl alcohol) for multi-use assay sampling or sterile 0.9% Normal Saline / PBS for immediate single-assay applications.
• Dilution Technique: Direct the diluent stream against the glass wall of the vial rather than spraying liquid directly onto the lyophilized cake. Allow the vial to sit at room temperature for 5–10 minutes, then gently swirl the glass. Never shake or vortex peptide solutions, as mechanical shear stress can denature cyclic peptide bonds.
• Aliquoting and Storage: Following complete dissolution, reconstituting research stock should be aliquoted into sterile microcentrifuge tubes and stored at -20°C or -80°C to prevent freeze-thaw degradation cycles.
When sourcing Melanotan 2 for analytical or in vitro research, PX1 Research provides institutional-grade consistency and complete supply chain transparency. Every order of MT-2 ships as a high-purity, lyophilized cake inside vacuum-sealed glass vials engineered to maintain sterility and structural stability.
Key operational parameters for PX1 Research orders include:
• Package Format: Sterile 10 mg lyophilized vials sealed with flip-off aluminium caps.
• Dispatch Timelines: Same-day shipping for all orders placed before 3:00 PM EST, Monday through Friday.
• Domestic Logistics: Rapid dispatch from fully climate-controlled fulfillment facilities in California and Arizona, complete with end-to-end tracking.
• COA Access: Publicly accessible, lot-specific HPLC/MS and endotoxin test results available directly through our online verification portal.
• Bulk Inquiries: Volume pricing and custom lot reservations available for high-throughput screening labs via our wholesale peptide program.
Secure reference-standard compounds for your facility today by visiting the official Melanotan 2 10 mg product page or exploring our complete catalog of USA-synthesized peptides.
Is Melanotan 2 legal to buy in the US?
Yes, Melanotan 2 is legal to purchase in the United States strictly for laboratory research, in vitro experimentation, and scientific evaluation. It is not approved for human consumption, medical treatment, or veterinary use.
What is the difference between Melanotan 1 and Melanotan 2?
Melanotan 1 (Afamelanotide) is a linear 13-amino-acid MSH analog with higher relative selectivity for MC1R. Melanotan 2 is a cyclic 7-amino-acid heptapeptide that exhibits enhanced metabolic stability and non-selective binding across MC1R, MC3R, MC4R, and MC5R.
What receptors does Melanotan 2 bind to?
In preclinical binding assays, Melanotan 2 acts as a non-selective agonist at melanocortin receptor subtypes MC1R, MC3R, MC4R, and MC5R, stimulating intracellular cAMP signaling pathways upon binding.
How fast does PX1 Research ship Melanotan 2?
PX1 Research dispatches all Melanotan 2 orders standard same-day when placed before 3:00 PM EST, Monday through Friday. Packages ship directly from fulfillment facilities in California and Arizona via tracked domestic shipping.
Do you provide a COA for my lot of Melanotan 2?
Yes, every batch of Melanotan 2 from PX1 Research includes a downloadable, lot-specific Certificate of Analysis detailing HPLC purity percentage, mass spectrometry identity confirmation, and quantitative endotoxin testing.
What purity level is required for in vitro Melanotan 2 research?
Rigorous in vitro and cell signaling research requires a minimum purity of 98.0%, with ideal analytical standards reaching ≥99.0% to prevent non-specific baseline cellular toxicity from truncated synthesis fragments.
How should Melanotan 2 be stored upon receipt in the lab?
Unreconstituted lyophilized vials should be stored at -20°C for long-term storage. Once reconstituted with sterile bacteriostatic water, liquid solutions should be refrigerated at 2–8°C and used within 30 days or frozen in single-use aliquots.
What is the molecular sequence and structure of Melanotan 2?
Melanotan 2 is a cyclic lactam-bridged heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 and an exact molecular weight of 1024.2 g/mol.
How is Melanotan 2 reconstituted for laboratory assays?
Reconstitute MT-2 by slowly adding sterile bacteriostatic water or saline down the glass vial wall, allowing it to dissolve naturally without agitation or vortexing to preserve the cyclic peptide bond structure.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.